DOI · e01.org

Early detection of colorectal cancer somatic mutations using cfDNA liquid biopsies in a murine carcinogenesis model

Héctor Martínez-Gregorio, Clara Estela Díaz-Velásquez, Mario Romero-Piña, Miguel Ruiz-de la Cruz, Norma L. Delgado‐Buenrostro, Aldo Hugo De La Cruz-Montoya, Yolanda I. Chirino, Luis Ignacio Terrazas, Luis A. Medina, Felipe Vaca‐Paniagua · Journal of Cancer · 2022

  • DOI 10.7150/jca.76516
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2022

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2022

Abstract

Colorectal cancer (CRC) is one of the top five cancers in incidence and mortality worldwide.The early detection of this neoplasm through analysis of circulating free DNA (cfDNA), which carries tumor genetic alterations, as a liquid biopsy, could have a major impact in enhancing early detection and reducing the mortality rate.The aim of this work was to demonstrate the feasibility of using cfDNA as a liquid biopsy for the early detection of CRC.For this purpose, we implemented an azoxymethane and dextran sodium sulfate-induced murine carcinogenesis model to detect oncogenic somatic mutations in Ctnnb1 and Kras during CRC development.To enhance the sensitivity in the detection, E-ice-COLD-PCR was utilized to selectively enrich for mutant alleles, followed by massively parallel sequencing.Driving somatic mutations were detected in Ctnnb1 and Kras in the liquid biopsies of early stages of tumor development, corresponding to the formation of aberrant crypt foci, the first histological alterations that can be identified throughout the formation of CRC.The concentration of cfDNA was increased along the carcinogenic process.Polyclonality in Ctnnb1 was found in tumor samples and cfDNA in this model.On the other hand, the use of cfDNA as a non-invasive test resulted in superior early detection compared to microPET/CT imaging.As a proof-of-principle, this study shows the great potential use of allelic-specific PCR for the detection and enrichment of pathogenic alleles present in cfDNA samples, as a test for early non-invasive detection of CRC.This work provides scientific evidence to set methodological bases that allow early detection of mutations in cfDNA obtained from plasma of CRC in humans.

Open the resolved locator · 10.7150/jca.76516

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:13 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v13p3404.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.